297 related articles for article (PubMed ID: 20442572)
1. New therapeutic developments in chronic migraine.
Lovell BV; Marmura MJ
Curr Opin Neurol; 2010 Jun; 23(3):254-8. PubMed ID: 20442572
[TBL] [Abstract][Full Text] [Related]
2. Emerging treatment for chronic migraine and refractory chronic migraine.
Lionetto L; Negro A; Palmisani S; Gentile G; Del Fiore MR; Mercieri M; Simmaco M; Smith T; Al-Kaisy A; Arcioni R; Martelletti P
Expert Opin Emerg Drugs; 2012 Sep; 17(3):393-406. PubMed ID: 22862686
[TBL] [Abstract][Full Text] [Related]
3. Chronic migraine: current concepts and ongoing treatments.
Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
Silberstein S; Diener HC; Lipton R; Goadsby P; Dodick D; Bussone G; Freitag F; Schwalen S; Ascher S; Morein J; Greenberg S; Biondi D; Hulihan J
Headache; 2008 Jul; 48(7):1087-95. PubMed ID: 18687081
[TBL] [Abstract][Full Text] [Related]
5. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB
Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982
[TBL] [Abstract][Full Text] [Related]
6. Migraine--the new understanding.
Ravishankar K
J Assoc Physicians India; 2010 Apr; 58 Suppl():30-3. PubMed ID: 21053438
[No Abstract] [Full Text] [Related]
7. The future of acute care and prevention in headache.
Krymchantowski AV; Rapoport AM; Jevoux CC
Neurol Sci; 2007 May; 28 Suppl 2():S166-78. PubMed ID: 17508166
[TBL] [Abstract][Full Text] [Related]
8. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
9. 14th International Headache Congress: clinical highlights.
Schwedt TJ; Silberstein SD
Headache; 2010 Mar; 50(3):509-19. PubMed ID: 20456145
[TBL] [Abstract][Full Text] [Related]
10. [Management of chronic daily headache in migraine patients: medication overuse headache and chronic migraine. French guidelines (French Headache Society, French Private Neurologists Association, French Pain Society)].
Lantéri-Minet M; Demarquay G; Alchaar H; Bonnin J; Cornet P; Douay X; Dousset V; Géraud G; Guillouf V; Navez M; Radat F; Radenne S; Revol A; Valade D; Donnet A
Rev Neurol (Paris); 2014 Mar; 170(3):162-76. PubMed ID: 24594364
[No Abstract] [Full Text] [Related]
11. Pathophysiology of chronic migraine and mode of action of preventive medications.
Mathew NT
Headache; 2011; 51 Suppl 2():84-92. PubMed ID: 21770930
[TBL] [Abstract][Full Text] [Related]
12. The face of chronic migraine: epidemiology, demographics, and treatment strategies.
Vargas BB; Dodick DW
Neurol Clin; 2009 May; 27(2):467-79. PubMed ID: 19289226
[TBL] [Abstract][Full Text] [Related]
13. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
Scott AK
Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
[TBL] [Abstract][Full Text] [Related]
14. What predicts the change from episodic to chronic migraine?
Bigal ME; Lipton RB
Curr Opin Neurol; 2009 Jun; 22(3):269-76. PubMed ID: 19381087
[TBL] [Abstract][Full Text] [Related]
15. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.
Diener HC; Dodick DW; Goadsby PJ; Bigal ME; Bussone G; Silberstein SD; Mathew N; Ascher S; Morein J; Hulihan JF; Biondi DM; Greenberg SJ
Cephalalgia; 2009 Oct; 29(10):1021-7. PubMed ID: 19735529
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of chronic daily headache.
Garza I; Schwedt TJ
Semin Neurol; 2010 Apr; 30(2):154-66. PubMed ID: 20352585
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistant chronic migraine: the Italian GON project.
Proietti Cecchini A; Leone M; Manzoni GC; Torelli P; Bussone G
Neurol Sci; 2012 May; 33 Suppl 1():S33-5. PubMed ID: 22644167
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA for the treatment of chronic migraine.
Rothrock JF
Headache; 2011 Apr; 51(4):659-60. PubMed ID: 21457253
[No Abstract] [Full Text] [Related]
19. Dihydroergotamine: role in the treatment of migraine.
Schürks M
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
[TBL] [Abstract][Full Text] [Related]
20. Migraine prevention.
Dodick DW; Silberstein SD
Pract Neurol; 2007 Nov; 7(6):383-93. PubMed ID: 18024778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
